Despite a drastic backslide in life expectancy that I reported on earlier this week—due in large part to the ongoing pandemic—many Americans are still becoming “super-agers.” In fact, in the last [...]
Despite a drastic backslide in life expectancy that I reported on earlier this week—due in large part to the ongoing pandemic—many Americans are still becoming “super-agers.” In fact, in the last [...]
Earlier this month, the Center for Medicare and Medicaid Services (CMS) announced it will only cover the cost of aducanumab—a new Alzheimer’s disease (AD) drug that I’ve talked about here [...]